Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss causes differ between men and women due to changes in hormone levels and inflammation-related pathways.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

ESR2 gene variations may be linked to female pattern hair loss.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Aromatase gene variation may increase female hair loss risk.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

Topical finasteride might be a good alternative for hair loss treatment with fewer side effects, but more research is needed.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.

Effective PCOS treatments require targeting specific signaling pathways.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Testosterone helps human pancreatic cells increase insulin release.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Chromosomal differences affect how muscle cells respond to testosterone.

Genetic mutations can affect female sexual development, requiring personalized medical care.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Glioblastoma cells can make androgens, which might help the tumor grow.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Melatonin may help treat PCOS symptoms in rats.